StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)

Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –

IRadimed pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

IRadimed's pe ratio was 48.4× on Nov 11, 2026, against 56.5× a year earlier. Over the last 5 years it ranged from 27.2× to 96.3×, with a median of 39.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202648.4×−10.6
2025Dec 31, 202559.0×+21.3
2024Dec 31, 202437.7×+0.9
2023Dec 29, 202336.8×+9.6
2022Dec 30, 202227.2×−69.1
2021Dec 31, 202196.3×+25.0
2020Dec 31, 202071.3×+35.8
2019Dec 31, 201935.4×−25.7
2018Dec 31, 201861.1×−55.4
2017Dec 29, 2017116.5×+100.5
2016Dec 30, 201616.1×−47.6
2015Dec 31, 201563.7×+10.0
2014Dec 31, 201453.8×–

More IRadimed figures

See a number that looks wrong?